Open AccessIn commemoration of the 2018 Mataro Nagayo Prize: A road to early diagnosis and monitoring of asbestos‐related mesothelioma
Author(s) -
Hino Okio,
Abe Masaaki,
Han Bo,
Yan Yan
Publication year - 2019
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/cas.14001
Subject(s) - mesothelioma , asbestos , peritoneal mesothelioma , medicine , disease , mesothelin , pathology , general surgery , intensive care medicine , oncology , materials science , metallurgy
Primarily caused by exposure to asbestos, mesothelioma is a typical occupational disease. The latency of mesothelioma is as long as 20‐40 years, and the cancer initially progresses mainly along the surfaces of pleura or peritoneum without forming masses. As symptoms do not develop until late stages, it has been challenging to diagnose this disease in its early stages and to carry out complete surgical removal. In responding to Japan's asbestos crisis in the mid‐2000s, we have developed and improved ERC/MSLN‐based serum and radiological markers and pioneered the use of an N‐ERC ELISA kit for screening populations at risk for asbestos exposure. In the present article, we review our research toward early diagnosis of asbestos‐related mesothelioma before symptoms develop and share our clinical experience of screening, diagnosing and monitoring of this disease. This paper is dedicated to the author (Dr Okio Hino) to commemorate the honor bestowed upon him as the recipient of the Mataro Nagayo Prize in 2018.